EDC for multi-site early phase trials: per-site access, centralized monitoring, and 21 CFR Part 11–aligned controls without enterprise overhead.
21 CFR Part 11–aligned · HIPAA-aligned security · No credit card required
One of the most important operational requirements in multi-site early phase trials is the ability to manage each site independently while maintaining centralized visibility and control. In Capture, each site operates within its own access boundary: coordinators and investigators at Site A see only Site A participants and data, while coordinators at Site B see only their own. This per-site isolation is enforced through role-based access controls, and all cross-site activities by monitors or sponsors are logged in the audit trail. This architecture supports the practical realities of multi-site early phase operations. Sites may be activated weeks or months apart, each with its own training timeline and go-live date. Different sites may have different IRB-approved consent form versions. Enrollment may be competitive, with some sites outperforming others. Capture handles all of these scenarios within a single study build, so the sponsor does not need to manage multiple separate studies or reconcile data across disconnected systems.
Multi-site early phase trials benefit from centralized monitoring approaches that go beyond traditional on-site SDV. With data from multiple sites flowing into one system, sponsors and CROs can apply risk-based monitoring strategies: reviewing key risk indicators across sites, identifying data quality patterns, and focusing monitoring effort where it is most needed. Capture supports this approach by providing monitors with cross-site data access, query workflows, and data quality indicators within the same platform used for data capture. Monitors can review CRF data, raise and resolve queries, and track site performance metrics without needing a separate monitoring tool. Medical monitors can review safety data, AE listings, and concomitant medication records across all sites from a single interface, enabling faster identification of safety signals that may only become apparent when data from multiple sites is viewed together.
Multi-site early phase studies that produce positive results often advance to larger confirmatory trials. When this transition happens, teams that ran their early-phase program on Capture have a structural advantage: the same CRF designs, consent workflows, visit structures, and export formats can be carried forward into the confirmatory study. Sites that participated in the early-phase study are already trained on the platform and can be reactivated without re-onboarding. This continuity reduces the time and cost of transitioning between study phases. Your data team retains familiarity with export structures and analysis pipelines. Your regulatory team can reference validation documentation from the early-phase study when qualifying the system for the confirmatory program. And your operational team can apply lessons learned from multi-site early phase—such as site performance patterns, common data quality issues, and effective monitoring strategies—directly to the larger program.
Overview
Multi-site early phase trials run across several investigator sites while still in Phase 1 or Phase 2. These programs are increasingly common in oncology, rare disease, and immunology, where enrolling enough participants at a single center is difficult and sponsor timelines demand parallel recruitment across geographically dispersed locations. The operational challenge is balancing site-level autonomy with centralized oversight: each site needs to capture data independently, but the sponsor and CRO need a unified view of enrollment, data quality, and safety signals across the entire program. Your EDC must support per-site access and visibility, centralized monitoring, and one audit trail—without the cost and complexity of global Phase 3 systems. Multi-site early phase teams are typically smaller than late-phase operations, which means the platform needs to be practical to deploy and maintain without a large dedicated project team at each site. At the same time, sponsor and regulatory expectations for data integrity, auditability, and role-based access are no different from larger programs. Capture provides EDC, eConsent, ePRO, and safety in one platform with role-based access per site, query and SDV workflows, and 21 CFR Part 11–aligned controls. Each site sees only its own participants and data, while sponsors, monitors, and data managers have cross-site visibility for oversight and monitoring. Because all modules are integrated, multi-site teams avoid the fragmentation and reconciliation issues that come with using separate systems at each site. Capture also supports the operational patterns common in multi-site early phase: staggered site activation, site-specific consent versions, competitive enrollment tracking, and centralized medical monitoring. As the study progresses, the same platform can scale to additional sites or transition into a larger Phase 2b or Phase 3 program without migration.
Multi-site early phase studies need more than single-site EDC but less than full global EDC. You need per-site roles, enrollment and data visibility by site, and monitoring and query workflows—without enterprise pricing and long implementation cycles. The challenge is finding a system that supports the multi-site model without requiring the infrastructure and budget of a registrational program. In practice, multi-site early phase studies face unique coordination challenges. Sites may activate at different times, creating staggered enrollment windows. Each site may have different IRB-approved consent versions that need to be tracked within the same study. Monitors need to review data across sites while maintaining clear attribution of which site produced which data. And the sponsor needs real-time enrollment visibility to make operational decisions about site performance and potential expansion. Enterprise EDC platforms designed for global Phase 3 programs often include features—multi-country regulatory workflows, central lab integrations, complex IVRS systems—that add cost and complexity without value for early phase. At the other end, single-site tools lack the access controls and monitoring infrastructure needed when multiple independent sites are contributing data to the same study. Capture supports multiple sites with one build, one audit trail, and documentation to support sponsor validation when required. The platform provides the multi-site infrastructure early phase teams need without the overhead that slows down larger enterprise systems.
FAQ
Explore the platform with a free sandbox. No sales call required.